Amneal Pharmaceuticals, Inc（AMRX）價格預測AMRXAmneal Pharmaceuticals, Inc

Alphio's AMRX stock price prediction model matches the current Amneal Pharmaceuticals, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.33 (+0.43%). The 1-week path is $18.99 (-1.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Amneal Pharmaceuticals Inc is a good buy right now due to its current price of $19.91, which is below the analyst price target of $27, indicating a potential upside of 35.5%. Additionally, the forward P/E ratio of 6.29 suggests that the stock is undervalued relative to its earnings potential. The recent FDA approval for the lanreotide injection and strong revenue growth, with a 104.21% increase over the past year, further supports this buy recommendation. However, the high debt to equity ratio of 8261.93% poses a significant risk to consider.

Amneal Pharmaceuticals, Inc (AMRX) last closed at $19.25, gaining +1.85%. These facts feed the 1-day and 1-week AMRX price prediction above.